Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers

Cancer, 05/21/2012

The National Comprehensive Cancer Network (NCCN)–Functional Assessment of Cancer Therapy–Hepatobiliary (FACT) Hepatobiliary–Pancreatic Symptom Index (NFHSI–18) assesses symptoms of importance to patients with hepatobiliary and pancreatic cancers and demonstrates promising measurement properties. The scale is a good candidate for brief symptom assessment in clinical trials.

Print Article Summary Cat 2 CME Report